Printer Friendly

CORDIS ANNOUNCES SLEEK LONG BALLOON CATHETERS APPROVED FOR U.S. MARKET RELEASE

 MIAMI, July 14 /PRNewswire/ -- Cordis Corporation (NASDAQ-NMS: CORD) said today that the Food and Drug Administration has approved the U.S. market release of Sleek PTCA Dilatation Catheters with 3 cm and 4 cm balloons (long balloons). Dilatation, or balloon, catheters are used to open coronary arteries occluded by the buildup of fatty deposits, or plaque, associated with atherosclerosis.
 Today's announcement follows by less than three weeks the agency's release of standard Sleek catheters, which feature 2 cm balloons. Long- balloon catheters address the needs of an expanding segment of the market in which clinical indications require the use of a balloon longer than the standard size. Both Sleek and Sleek long balloon devices are compatible with up to an .014" guidewire and thus compete in the largest segment of the U.S. angioplasty market.
 Robert C. Strauss, president and chief executive officer, praised the speed with which the new devices went through the regulatory process. "The rapid addition of long balloons to our product portfolio," he said, "is certain to make the Sleek catheter line even more attractive to coronary angioplasters."
 The approval of Sleek long balloon catheters increases to nine the number of Cordis dilatation catheters to gain FDA approval in the past 12 months. Moreover, with the four new catheters announced June 24, Sleek long balloons represent the fifth line of devices to be introduced in recent weeks.
 Miami-based Cordis Corporation manufactures and markets a variety of medical devices and systems for the angiographic and neuroscience markets.
 -0- 7/14/93
 /CONTACT: Chick McDowell, vice president, corporate relations and assistant secretary of Cordis Corporation, 305-824-2821/
 (CORD)


CO: Cordis Corporation ST: Florida IN: MTC SU:

AW-PC -- FL002 -- 1222 07/14/93 08:59 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 14, 1993
Words:286
Previous Article:IBM OPENS OFFICE OF THE FUTURE IN LOUISVILLE
Next Article:JACOBS ENGINEERING WILL PROVIDE ENGINEERING SERVICES FOR EXPANSION
Topics:


Related Articles
TWO NEW CORDIS ANGIOPLASTY CATHETERS GAIN U.S. MARKET RELEASE
CORDIS' SLEEK CATHETER RECEIVES "APPROVABLE LETTER"
FOUR CORDIS ANGIOPLASTY CATHETERS APPROVED FOR US MARKET RELEASE
ANOTHER CORDIS ANGIOPLASTY CATHETER APPROVED FOR US MARKET RELEASE
CORDIS PREDATOR LONG BALLOON CATHETERS APPROVED FOR U.S. MARKET RELEASE
CORDIS INTRODUCES NEW ANGIOPLASTY CATHETER LINE
CORDIS RECEIVES LETTER FROM FDA
CORDIS TITAN ANGIOPLASTY CATHETERS APPROVED FOR U.S. MARKET RELEASE
Cordis Corporation and ClearStream Technologies Group, plc, Sign Distribution Agreement for Peripheral Angioplasty Balloon Catheters.
Cordis Corporation and ClearStream Technologies Group, plc, Sign Distribution Agreement for Peripheral Angioplasty Balloon Catheters.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters